BIVI - CIK 0001580149
The table below shows BIOVIE INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$19.03M | -$27.95M | -$40.25M | -$18.99M | -$10.45M | -$1.63M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | - | $14.53M | -$14.30M | - | - | - |
| Dividends paid | - | - | - | - | - | - |
BIOVIE INC. reported operating cash flow of -$19.03M for fiscal year 2025. That is up 31.9% from -$27.95M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$153.63K (FY 2016) to -$19.03M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $12.73M | $17.80M | $55.37M | $33.12M | $14.93M | $1.33M |